| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/21/2004 | EP1409034A1 Topical pharmaceutical formulation |
| 04/21/2004 | EP1409023A1 Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms |
| 04/21/2004 | EP1409022A1 Pharmaceutical vehicle |
| 04/21/2004 | EP1409021A2 Formulation comprising fulvestrant |
| 04/21/2004 | EP1409020A1 Antacid chewing gum products coated with high viscosity materials |
| 04/21/2004 | EP1409018A2 Stable lyophilized pharmaceutical formulation of igg antibodies |
| 04/21/2004 | EP1409010A1 Treating endotoxemia and related disorders with probiotics |
| 04/21/2004 | EP1409002A1 Spheroids based on plant extract adsorbates and method for preparing same |
| 04/21/2004 | EP1408999A1 Compositions addressing inflammation and/or degenerative disorders |
| 04/21/2004 | EP1408996A2 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 04/21/2004 | EP1408982A1 Pharmaceutical compositions for treatment of digestive disorders and associated diseases |
| 04/21/2004 | EP1408968A2 Receptor-adapted nicotine withdrawal by anti-cholinergic and anti-noradrenergic blockage |
| 04/21/2004 | EP1408967A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 04/21/2004 | EP1408956A1 Uses of metal salts to stabilize taxane-based compositions |
| 04/21/2004 | EP1408948A2 Thyroid therapeutic agent |
| 04/21/2004 | EP1408947A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 04/21/2004 | EP1408943A2 Pharmaceutical formulation containing an ltb4 antagonist |
| 04/21/2004 | EP1408942A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 04/21/2004 | EP1408935A2 Process for the preparation of medicated gums |
| 04/21/2004 | EP1408934A2 Pharmaceutical composition for prophylaxis and treatment of calcium metabolism disorders comprising clodronate in combination with glyceryl palmitostearate |
| 04/21/2004 | EP1408933A2 Sildenafil citrate chewing gum formulations and methods of using the same |
| 04/21/2004 | EP1408932A1 Particles with improved solubilization capacity |
| 04/21/2004 | EP1408931A1 Modifying the fatty acid composition of cell membranes of organs and tissues |
| 04/21/2004 | EP1408930A1 Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions |
| 04/21/2004 | EP1408929A2 Ophthalmic composition containing n-acetylcysteine for the treatment of dry-eye syndrom |
| 04/21/2004 | EP1408921A1 Composition for oral hygiene comprising a fluoride ion vector and an antioxidant |
| 04/21/2004 | EP1408911A1 Sustained-release therapeutic bioadhesive systems |
| 04/21/2004 | EP1408907A2 Metering and packaging of controlled release medication |
| 04/21/2004 | EP1408897A2 Gum resin as a carrier for topical application of pharmacologically active agents |
| 04/21/2004 | EP1408876A1 Zero-order prolonged release coaxial implants |
| 04/21/2004 | EP1408772A2 Methods of stabilizing fruit-concentrate powders |
| 04/21/2004 | EP1408769A2 A process for the preparation of medicated chewing gums |
| 04/21/2004 | EP1408768A1 SUGAR-FREE HARD COATINGS PREPARED FROM LIQUID MALTITOL COMPRISING DP sb 4+ /sb FRACTION |
| 04/21/2004 | EP1408757A2 Method and composition for prolonging the residence time of drugs in the gut |
| 04/21/2004 | EP1408750A2 A cream-t0-powder dermatological composition |
| 04/21/2004 | EP1305049A4 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 04/21/2004 | EP1267900B1 Emulsion containing a triterpen containing plant extract, method for producing said emulsion and for obtaining a plant extract |
| 04/21/2004 | EP1200092B1 Beta-carboline drug products |
| 04/21/2004 | EP1183016B1 Stereocomplex hydrogels |
| 04/21/2004 | EP1181036A4 Pharmaceutical compositions of erythropoietin |
| 04/21/2004 | EP1178783B1 Device and use for increasing the transdermal permeation of medicaments |
| 04/21/2004 | EP1121099B1 Pharmaceutical composition with gastric residence and controlled release |
| 04/21/2004 | EP1112074B1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 04/21/2004 | EP1007030B1 Solid pharmaceutical composition containing benzofurane derivatives |
| 04/21/2004 | EP0941095B1 Improved pharmaceutical compositions |
| 04/21/2004 | EP0909168B1 Propellant mixtures and aerosols for micronising medicaments with compressed gas |
| 04/21/2004 | EP0839024B1 Monensin formulations |
| 04/21/2004 | EP0693924B1 Methods for (in vivo) delivery of biologics and compositions useful therefor |
| 04/21/2004 | CN1491232A Modified leptin with reduced immunogenicity |
| 04/21/2004 | CN1491231A Modified keratinocyte growth factor (KGF) with reduced immunogenicity |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1491117A Compositions containing inclusion complexes |
| 04/21/2004 | CN1491114A Compositions for nasal administration of insulin |
| 04/21/2004 | CN1491108A Antifungal remedy formulation for external application |
| 04/21/2004 | CN1491105A Novel modified released formulation |
| 04/21/2004 | CN1491104A Novel modified release formulation |
| 04/21/2004 | CN1491102A Ophthalmic compositions |
| 04/21/2004 | CN1491089A Composition and method for smoke detoxification |
| 04/21/2004 | CN1490333A Insulinotropic peptide and its use |
| 04/21/2004 | CN1490055A Method for preparing nanometre structure medicine |
| 04/21/2004 | CN1490048A Method for improving oral drug living thing availability, composition and reagent box |
| 04/21/2004 | CN1490047A Chinese medicine composition for travelling health-protection and preparing method thereof |
| 04/21/2004 | CN1490046A Chinese medicine for cardiac and encephalic ischemia |
| 04/21/2004 | CN1490044A Medicine for treating osteoproliferation |
| 04/21/2004 | CN1490041A Cottonrose hibiscus leaf and magnolia bark containing medicines against catch-cold and preparation thereof |
| 04/21/2004 | CN1490040A Method for treating hypoleucocytosis |
| 04/21/2004 | CN1490033A Chinese medicinal preparations for chronic bronchitis and obstructive emphysema |
| 04/21/2004 | CN1490032A Dispersed snake gall and Sichuan fritillary bulb tablets and their preparation |
| 04/21/2004 | CN1490026A Bear gall lozenge and preparing method thereof |
| 04/21/2004 | CN1490025A Bear gall granular formulation and preparing method thereof |
| 04/21/2004 | CN1490016A Bougie for treating virus hepatitis and preparing method thereof |
| 04/21/2004 | CN1490015A Thevina drops and preparation thereof |
| 04/21/2004 | CN1490014A Mangiferin preparation and production thereof |
| 04/21/2004 | CN1490012A Zine glycyrrhizate drops and preparation thereof |
| 04/21/2004 | CN1490011A Methanesulfonic pazuthacin injection and its preparing process against infection |
| 04/21/2004 | CN1490010A Methanesul fonic pazuthacin injection and its preparing process against infection |
| 04/21/2004 | CN1490009A Sustained release injection containing medicine against coccindian |
| 04/21/2004 | CN1490008A Minlpress hydrochloride drops and preparation thereof |
| 04/21/2004 | CN1490007A Quinoline coridalis B drops and preparation thereof |
| 04/21/2004 | CN1490006A Melazocine masticatory and its preparation |
| 04/21/2004 | CN1490005A Berberine or berberine salts drops and their preparation |
| 04/21/2004 | CN1490004A Freeze-dried tinidazole preparation and preparing method thereof |
| 04/21/2004 | CN1490002A Enalapril drops and preparation thereof |
| 04/21/2004 | CN1490001A Hepadestal drops and preparation thereof |
| 04/21/2004 | CN1490000A Hippophae rhamnoide flavone drops and preparation thereof |
| 04/21/2004 | CN1489998A Isosorbide dinitrate drops and preparation thereof |
| 04/21/2004 | CN1489996A Diclofenac sodium pastes and preparation thereof |
| 04/21/2004 | CN1489995A Amitriptyline hydrochloride drops and preparation thereof |
| 04/21/2004 | CN1489994A Extracts of fat soluble benzyl ethene contents from curcuma longa and use in preparation |
| 04/21/2004 | CN1489992A Autonomic soft capsules and producing process thereof |
| 04/21/2004 | CN1489991A Preparation of durable Chinese medicine and healthy food effervescent tablets |
| 04/21/2004 | CN1489990A Preparing method for superfine Chinese medicine jellies |
| 04/21/2004 | CN1146578C Process for making cellulose ethers having reduced yellowing and discoloration |
| 04/21/2004 | CN1146444C Vaccine composition comprising polysaccharide conjugate antigen and adsorbed onto aluminium phosphate |
| 04/21/2004 | CN1146436C Ointment for treating gastrosis by fomentation |
| 04/21/2004 | CN1146430C Methods of decreasing or preventing pain using spicamycin or derivatives thereof |
| 04/21/2004 | CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent |
| 04/21/2004 | CN1146428C Crystallized pirimiphos-methyl composite and its preparation and usage |
| 04/21/2004 | CN1146427C Solid oral dosage form comprising combination of metformin and glibenclamide |
| 04/21/2004 | CN1146426C Stable aspirin-containing preparations for external use |